Evidence map›Paper›PMID 34502089›Full record

ArticleInternational journal of molecular sciences2021

ATG101 Degradation by HUWE1-Mediated Ubiquitination Impairs Autophagy and Reduces Survival in Cancer Cells.

JaeYung Lee, Jiyea Kim, Jeongeun Shin, YongHyun Kang, Jungwon Choi, Heesun Cheong

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. The mitophagy pathway and its implications in human diseases.Signal transduction and targeted therapy · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Degradation Mechanism of Autophagy-Related Proteins and Research Progress.International journal of molecular sciences · 2022
    Review
  11. The roles of KLHL family members in human cancers.American journal of cancer research · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

JaeYung LeeDepartment of Cancer Biomedical Science, Graduate School of Cancer Science & Policy, National Cancer Center, Goyang-si 10408, Korea.
Jiyea KimDepartment of Cancer Biomedical Science, Graduate School of Cancer Science & Policy, National Cancer Center, Goyang-si 10408, Korea.
Jeongeun ShinDepartment of Cancer Biomedical Science, Graduate School of Cancer Science & Policy, National Cancer Center, Goyang-si 10408, Korea.
YongHyun KangDepartment of Cancer Biomedical Science, Graduate School of Cancer Science & Policy, National Cancer Center, Goyang-si 10408, Korea.
Jungwon ChoiDivision of Cancer Biology, Research Institute, National Cancer Center, Goyang-si 10408, Korea.
Heesun CheongDepartment of Cancer Biomedical Science, Graduate School of Cancer Science & Policy, National Cancer Center, Goyang-si 10408, Korea.ORCID 0000-0003-1946-107X
National Cancer Center · KR

Funding

National Cancer Center 2110120National Research Foundation of Korea NRF-2020R1A2B5B01002011Women In Science, Engineering and Technology (WISET) 2020-632
6 · The paper itself

Abstract

Autophagy is a critical cytoprotective mechanism against stress, which is initiated by the protein kinase Unc-51-like kinase 1 (ULK1) complex. Autophagy plays a role in both inhibiting the progression of diseases and facilitating pathogenesis, so it is critical to elucidate the mechanisms regulating individual components of the autophagy machinery under various conditions. Here, we examined whether ULK1 complex component autophagy-related protein 101 (ATG101) is downregulated via ubiquitination, and whether this in turn suppresses autophagy activity in cancer cells. Knockout of ATG101 in cancer cells using CRISPR resulted in severe growth retardation and lower survival under nutrient starvation. Transfection of mutant ATG101 revealed that the C-terminal region is a key domain of ubiquitination, while co-immunoprecipitation and knockdown experiments revealed that HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1(HUWE1) is a major E3 ubiquitin ligase targeting ATG101. Protein levels of ATG101 was more stable and the related-autophagy activity was higher in HUWE1-depleted cancer cells compared to wild type (WT) controls, indicating that HUWE1-mediated ubiquitination promotes ATG101 degradation. Moreover, enhanced autophagy in HUWE1-depleted cancer cells was reversed by siRNA-mediated ATG101 knockdown. Stable ATG101 level in HUWE1-depleted cells was a strong driver of autophagosome formation similar to upregulation of the known HUWE1 substrate WD repeat domain, phosphoinositide interacting 2 (WIPI2). Cellular survival rates were higher in HUWE1-knockdown cancer cells compared to controls, while concomitant siRNA-mediated ATG101 knockdown tends to increase apoptosis rate. Collectively, these results suggest that HUWE1 normally serves to suppress autophagy by ubiquitinating and triggering degradation of ATG101 and WIPI2, which in turn represses the survival of cancer cells. Accordingly, ATG101-mediated autophagy may play a critical role in overcoming metabolic stress, thereby contributing to the growth, survival, and treatment resistance of certain cancers.

Indexed as

AutophagyUbiquitinationAutophagy-Related ProteinsCell SurvivalHEK293 CellsHeLa CellsHumansMembrane ProteinsNeoplasmsPhosphate-Binding ProteinsTumor Suppressor ProteinsUbiquitin-Protein LigasesVesicular Transport ProteinsATG101 protein, humanAutophagy-Related ProteinsHUWE1 protein, humanMembrane ProteinsPhosphate-Binding ProteinsTumor Suppressor ProteinsUbiquitin-Protein LigasesVesicular Transport ProteinsWIPI2 protein, humanautophagyautophagy-related gene 101(ATG101)cancerE3 ubiquitin ligaseHECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1(HUWE1)mitophagyubiquitinationUnc-51-like kinase 1(ULK1)WD repeat domain, phosphoinositide interacting 2 (WIPI2)

Identifiers

PMID34502089
PMCPMC8430637
OpenAlexW3196247681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.